Cape Investment Advisory’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$228K Sell
631
-42
-6% -$14.4K 0.06% 214
2026
Q1
$237K Sell
673
-22
-3% -$7.84K 0.08% 205
2025
Q4
$227K Buy
695
+85
+14% +$27K 0.07% 196
2025
Q3
$172K Sell
610
-26
-4% -$7.54K 0.17% 124
2025
Q2
$178K Sell
636
-58
-8% -$16.4K 0.06% 196
2025
Q1
$216K Sell
694
-41
-6% -$12.1K 0.09% 170
2024
Q4
$192K Buy
735
+12
+2% +$3.56K 0.07% 175
2024
Q3
$233K Sell
723
-1
-0.1% -$327 0.09% 157
2024
Q2
$226K Sell
724
-17
-2% -$4.99K 0.1% 138
2024
Q1
$211K Sell
741
-5
-0.7% -$1.46K 0.1% 139
2023
Q4
$215K Buy
746
+35
+5% +$9.54K 0.11% 138
2023
Q3
$191K Buy
711
+45
+7% +$11.2K 0.11% 140
2023
Q2
$148K Buy
666
+36
+6% +$8.35K 0.08% 163
2023
Q1
$152K Buy
+630
New +$155K 0.09% 150

Other funds holding AMGN

Cape Investment Advisory's AMGN Position: Q2 2026 in Review

Cape Investment Advisory reduced its Amgen (AMGN) stake by 6.2% in Q2 2026, selling an estimated $14.4K and leaving 631 shares worth $228K. The position accounts for 0.06% of the portfolio, ranked #214.

Cape Investment Advisory first reported a position in AMGN in Q1 2023 and has held it in 14 quarters since. The position peaked at $237K in Q1 2026. 1,372 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Cape Investment Advisory held 631 shares of Amgen worth $228K as of Q2 2026.
  • Cape Investment Advisory sold 42 Amgen shares in Q2 2026, an estimated $14.4K.
  • Amgen made up 0.06% of Cape Investment Advisory's portfolio in Q2 2026, its #214 holding.
  • Cape Investment Advisory first reported a position in Amgen in Q1 2023 and has held it in 14 quarters since.
  • Cape Investment Advisory's Amgen position peaked at $237K in Q1 2026.
  • 1,372 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Cape Investment Advisory's 13F filing for Q2 2026, filed 23 Jul 2026.